They found that higher levels of m-nectin-4 expression are significantly associated with a lower disease-free survival (DFS) rate and a lower distant recurrence-free survival (DRFS) rate in patients with luminal-A breast cancer. This evidence concerns the gene NECTIN4 and breast carcinoma.